Skip to content

NeoGenomics NEO Increase (Decrease) in Deferred Income Taxes

Increase (Decrease) in Deferred Income Taxes at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$186.7M+11.1%
Gross profit$80.9M+10.4%
Operating income-$18.2M+34.4%
Net income-$17.1M+34.0%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$146.1M-57.8%
Total debt$66.3M+5.3%
Total equity$828.8M-6.7%
Total assets$1.3B-15.9%

Cash flow

See full
Operating cash flow-$8.1M+67.9%
CapEx$5.0M+11.1%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$1.79B+98.5%
Enterprise value$1.71B+177%
P/S2.4×+1.1×

Profitability

See full
Gross margin43.2%-1.1pp
Operating margin-14.2%+1.1pp
Net margin-13.3%+2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-11.6%+6.2pp
Debt / equity0.1×0.0×
Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredIncomeTaxes.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's increase (decrease) in deferred income taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NeoGenomics's increase (decrease) in deferred income taxes?
NeoGenomics (NEO) reported increase (decrease) in deferred income taxes of $769K in Q1 2026.
How has NeoGenomics's increase (decrease) in deferred income taxes changed year-over-year?
NeoGenomics's increase (decrease) in deferred income taxes increased by 42.1% year-over-year, from $541K to $769K.
What is the long-term trend for NeoGenomics's increase (decrease) in deferred income taxes?
Over 3 years (2021 to 2024), NeoGenomics's increase (decrease) in deferred income taxes has grown at a -21.3% compound annual growth rate (CAGR), from $6.3M to $3.07M.